Cancer

View All

HER2-Positive Breast Cancer
Metastatic HER2-Positive Breast Cancer

Breast cancer is not a single disease leading to abnormal cell division in breast tissues. In the United States, it is estimated that more than 40,000 women will die from breast cancer in 2017. According to DelveInsight’s estimates, the total Breast cancer incident population in the 7MM was found to be 626,867 in 2...

Find More

Pharma News
HiFiBio raises USD 67 M; FDA drafts new guidelines for Breast cancer trials; Harbour BioMed teams up with Pharmaceutical Product Development

FDA urges Pharma giants to increase their inclusion of men in new Breast Cancer trials The recent FDA recommendations have urged the Pharma companies for the inclusion of men in the clinical trials to test new breast cancer drugs. Men rarely develop Breast cancer. Less than 1% of men develop Breast cancer. And 1...

Find More

Pharma News
Juvenescence nets USD 100M; Sarepta DMD drug faces rejection

Juvenescence closes a USD 100 Million Series B round Juvenescence, a life sciences company focused on treating ageing problems, has successfully raised USD 100 Million in a Series B round. The investors who took part in the funding were Grok Ventures, the investment company of Mike Cannon-Brookes (Atlassian co-...

Find More

FDA approval for Nubeqa; Biodesix, Immodulon collaborates on Cancer treatment; Cancer asset rights to Alligator Bioscience

Bayer and Orion's Nubeqa gets FDA recommendations for Prostate Cancer The U.S. FDA has given its nod to Nubeqa (darolutamide) for the treatment of patients with non-metastatic castration-resistant prostate cancer (nmCRPC). Nubeqa is a steroidal androgen receptor inhibitor (ARi), and its recommendation came afte...

Find More

Pharma News
Baqsimi wins FDA nod for Hypoglycemia; Freenome captures USD 160M; FDA approval for Ruxience for leukaemia

FDA Approves Eli Lilly's Baqsimi, the first treatment for Severe Hypoglycemia The U.S. FDA gave its approval to Baqsimi nasal powder, for the treatment of Severe Hypoglycaemia in patients with diabetes ages four and older. Baqsimi is a powder administered into the nose and is the first non-injectable emergency t...

Find More

World Pharma News
The Business Cocktail

Gilead jumps into a competitive Protein degradation field, signs a USD 45 M Nurix deal Gilead Sciences is turning to Nurix Therapeutics for enhancing cancer pipeline. Gilead is ready to pay USD 45 million upfront, and if all the targets are achieved the deal could reach up to USD 2.3 billion. Nurix is a drug de...

Find More

Brain tumor
World Brain Tumor Day

World Brain Tumor Day World Brain Tumor Day is focussed at raising awareness about brain tumor and educating people about cancer which is not very common. Every year, June 8 is seen as World Brain Tumor Day. The day is also meant for those who are suffering from a brain tumor and help them deal with the condi...

Find More

Pharma Business news
The Business Cocktail

Cancer biotech Inhibrx files for USD 75 M IPO Celgene-partnered biotech Inhibrx aftersecuring USD 40 Million from Viking Global Investors, has filed for USD 75 million IPO. Built on a single-domain antibody platform, it has three oncology programs in human clinical trials, a rare disease program, and two preclin...

Find More

WORLD NO TOBACCO DAY

WORLD NO TOBACCO DAY Every year, 31st May is observed as World Tobacco Day. This day is intended to spread awareness about health issues associated with tobacco use and to encourage the government to adopt effective policies to reduce the use of tobacco products. Every year, approximately 7 million people die du...

Find More

gene therapy in oncology
Gene Therapy in Oncology: Innovation to Commercialization

Gene Therapy is a way to introduce a normal working gene in the place of a mutated one which might result in some kinds of abnormalities. Gene Therapy is a novel way to express novel proteins, and re-design the genome to prevent any disease. The concept here is some disorders are caused due to their defect in a sin...

Find More